Detalhe da pesquisa
1.
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer.
J Clin Oncol
; 41(9): 1638-1645, 2023 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921335
2.
Effects on quality of life of combined trastuzumab and chemotherapy in women with metastatic breast cancer.
J Clin Oncol
; 20(14): 3106-13, 2002 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12118024
3.
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.
J Clin Oncol
; 20(3): 719-26, 2002 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11821453